SCHEMBL3658418

SCHEMBL3658418

Cc1cc(NC(=O)COc2ccccc2)ccc1[N+]1(C2CCNC2)CCCC1C

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
POLB P06746 2/20 0.46
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3650309 0.83 KMT2A (0.50) NPC1MEN1KMT2AALDH1A1GAA
SCHEMBL3658726 0.83 CYP1A2 (0.44) NPC1POLBMAPTKDM4EMAPK1
Trifluoroacetic Acid SCHEMBL3655787 0.82 MLYCD (0.46) NPC1POLBMAPTKDM4EMEN1
SCHEMBL3650124 0.81 HSP90AA1 (0.50) NPC1MAPTKDM4EMAPK1MEN1
SCHEMBL3655153 0.81 NPC1 (0.43) NPC1MAPTKDM4EMEN1KMT2A
Trifluoroacetic Acid SCHEMBL3653647 0.80 KMT2A (0.45) NPC1MEN1KMT2AALDH1A1GAA
SCHEMBL3658289 0.79 KMT2A (0.45) NPC1MAPTMEN1KMT2AALDH1A1
Trifluoroacetic Acid SCHEMBL3651075 0.79 CYP1A2 (0.40) NPC1POLBMAPTKDM4EMEN1
Trifluoroacetic Acid SCHEMBL3657556 0.79 HSP90AA1 (0.45) NPC1POLBMAPTKDM4EMEN1
SCHEMBL3652477 0.78 ESR1 (0.45) NPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212282-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052065-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed